ArticlePloS one2026
Identification of risk areas and associated factors of unfavorable treatment outcomes in drug-resistant tuberculosis: Evidence from Rio de Janeiro, Brazil.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-resistant tuberculosis remains a major challenge to tuberculosis control in Brazil and worldwide.
objectiveTo identify factors associated with unfavorable treatment outcomes and to analyze the occurrence of high-risk spatial clusters at an intra-urban scale in the municipality of Rio de Janeiro, Brazil.
methodsA retrospective cohort study of drug-resistant tuberculosis cases reported between 2015 and 2022 was conducted. Individual-level and spatial analyses were performed to identify associated factors with unfavorable outcomes and high-risk clusters.
resultsOf the 972 cases analyzed, 31.6% had unfavorable outcomes, including 20.2% lost to follow-up, 4.9% with treatment failure, and 6.3% deaths. Loss to follow-up was higher among males, Black individuals, those with low education levels, individuals with AIDS, and those who used alcohol, tobacco, or illicit drugs, whereas older age and diabetes were associated with lower odds. Treatment failure was more frequent among individuals of Brown race/skin color, those with multidrug-resistant and extensively drug-resistant tuberculosis, and those with multiple previous treatments. Mortality was higher among individuals over 40 years of age, those with multidrug-resistant and extensively drug-resistant tuberculosis, those with alcohol use, and individuals AIDS. Three high-risk spatial clusters were identified in the northern zone of the city, an area of marked social vulnerability.
conclusionUnfavorable drug-resistant tuberculosis outcomes are influenced by socioeconomic factors, particularly in socially vulnerable urban areas. In this context, strengthening local surveillance in identified high-risk clusters, improving patient-centered care across primary and secondary levels, and providing robust socioeconomic support are essential strategies for reducing unfavorable outcomes and achieving more equitable tuberculosis control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.